FDA.reportPublic FDA data

nedosiran 80 MG in 0.5 ML Injection

RxCUI
2675303
RxNorm name
nedosiran 80 MG in 0.5 ML Injection
Display name
nedosiran 80 MG in 0.5 ML Injection
Full name
nedosiran 80 MG in 0.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RIVFLOZANEDOSIRANNovo Nordiskace9d4bc-4d20-4beb-9e9d-8886904248332025-03-03Adverse reactionsExact identifier
rxcui: 2675303

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ace9d4bc-4d20-4beb-9e9d-888690424833nedosiran 80 MG in 0.5 ML Injection [PSN] · 0.5 ML nedosiran 160 MG/ML Injection [SCD] · nedosiran 80 MG (as nedosiran sodium 85 MG) per 0.5 ML Injection [SY]34These highlights do not include all the information needed to use RIVFLOZA safely and effectively. See full prescribing information for RIVFLOZA. RIVFLOZA ® (nedosiran) injection, for subcutaneous use Initial U.S. Approval: 202320250303